Aegea Medical, Inc., a Redwood City, Calif.-based medical technology company focused on the women’s health space, secured $40m in funding.
This included a $30m financing from Perceptive Advisors and an additional $10m from its existing equity investors including Alloy Ventures, Delphi Ventures, Medtronic, BioMed Ventures, and Solas BioVentures.
This financing provides capital to fund operations while the company prepares to launch commercially in the US.
Founded in 2008 and led by Don Gurskis, President and CEO, Aegea Medical focuses on the development of its patented Adaptive Vapor Ablation technology for endometrial ablation. The company’s system is an FDA-approved endometrial ablation system specifically designed to treat menorrhagia, or abnormal uterine bleeding, in the doctor’s office with minimal anesthesia/analgesia and rapid recovery.